Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects.

Saved in:
Bibliographic Details
Title: Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects.
Authors: Lauring B (AUTHOR), Dishy V (AUTHOR), Luo W (AUTHOR), Laterza O (AUTHOR), Patterson J (AUTHOR), Cote J (AUTHOR), Chao A (AUTHOR), Larson P (AUTHOR), Gutierrez M (AUTHOR), Wagner JA (AUTHOR), Lai E (AUTHOR)
Source: Journal of Clinical Pharmacology. Dec2009, Vol. 49 Issue 12, p1426-1435. 10p.
Database: Academic Search Ultimate
Description
ISSN:00912700
DOI:10.1177/0091270009339593